The efficacy and safety of IBI314 on delta and omicron variant of SARS-CoV-2: First-in-human evidence

J Infect. 2022 Sep;85(3):334-363. doi: 10.1016/j.jinf.2022.06.004. Epub 2022 Jun 9.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19*
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • SARS-CoV-2*
  • Spike Glycoprotein, Coronavirus

Substances

  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2

Supplementary concepts

  • SARS-CoV-2 variants